HumanCytoSNP-12 microarray           

The illumina HumanCytoSNP-12 microarray is the first gene chip developed for clinical detection based on SNP gene chip technology.
Its advantages are as follows:
▪ Multiple sites and wide coverage: 300,000 SNP detection sites covering the entire genome, including 245 diseases or regions;
• Easy operation: the sample extraction volume is as low as 200ng, and the test report is issued within 48 hours;
• Using improved whole-genome amplification technology to overcome the problem of primer design for PCR technology;
▪ Low cost: chip cost includes all reagents, one-stop purchase;
• Dual quality control: repeatability> 99.9%, effectively guaranteeing data quality;